In recent years, EVI5, an important protein regulating cell cycle [32] and migration [20], has been increasingly reported to be associated with HCC [24], bladder cancer [33], melanoma [34], leukemia [35], lymphoma [25] and many other tumors. Here, EVI5 is linked to hepatocellular carcinoma.